TF and adenocarcinoma: We further confirmed TF expression through immunohistochemistry using a large set of archived patient tissues and demonstrated activity in both squamous and adenocarcinoma cell lines, thereby highlighting the broad applicability of TF-BiTE in different cervical cancer subtypes.